Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014
Scientists working in the field of Alzheimer's disease and, in particular, cognitive enhancers, are very productive. The review "Drugs interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs" was accepted in October 2012. In the last 20 months, new targets for the potential treatment of Alzheimer's disease were identified. Enormous progress was realized in the pharmacological characterization of natural products with cognitive enhancing properties. This review covers the evolution of research in this field through May 2014.
Keywords: Amyloid-beta aggregation inhibitors ; antibodies ; antioxidants ; cognitive enhancers ; metal chelators ; natural products ; nootropics ; peptides ; psychostimulants ; stem cells ; tau ; vaccines
Record created on 2014-12-30, modified on 2016-08-09